Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy.
D000284:Administration, Oral; D000818:Animals; D001702:Biopharmaceutics; D002415:Cats; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D006168:Guinea Pigs; D006207:Half-Life; D006331:Heart Diseases / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000503:physiopathology; D007700:Kinetics; D008962:Models, Theoretical; D011485:Protein Binding; D011863:Radioimmunoassay; D012709:Serum Albumin / Q000378:metabolism; D012996:Solutions; D013607:Tablets; D014316:Tritium; D006113:United Kingdom; D014481:United States
D012709:Serum Albumin; D012996:Solutions; D013607:Tablets; D014316:Tritium; D004077:Digoxin